Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Substance Abuse, Substance Use Disorder (SUD)_Opioid, Alcohol, Tobacco, Etc.
AtaiBeckley Inc, formerly, Atai Life Sciences N.V. (NASDAQ:ATAI)*

Organization & Developments: ATAI Life Sciences

Parents

*atai – Pioneering the development of more effective and potentially disease-modifying mental health treatments
*Biotechnology company pioneering mental health innovation by developing more effective and potentially disease-modifying mental health treatments by researching both psychedelic and non-psychedelic compounds.
*Clinical-stage biopharmaceutical company focused on developing treatments on various mental health disorders
*Developing therapies for mental health conditions like treatment-resistant depression and anxiety disorder.
*Perception Neuroscience, a subsidiary of atai Life Sciences
*Recognify Life Sciences
2021: Peter Thiel-backed psychedelics start-up plans to raise $100 million in IPO_ www.cnbc.com
2022: Atai Life Sciences N.V.: A First Take_seekingalpha.com
2023: atai's Ketamine-Based Depression Candidate Falls Short in Phase II
2025: Atai Life Sciences: Positive BPL-003 Data In AUD Leads To Another Catalyst